British American Tobacco PLC
02 January 2008
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
Notification made in accordance with Disclosure Rule 3.1.4R(1)(a) of the
Disclosure Rules sourcebook.
The Company was notified on 2 January 2008 that, on the same day, the following
persons discharging managerial responsibilities acquired British American
Tobacco p.l.c. 25p ordinary shares (the "Shares") following the exercise of
options held under the British American Tobacco Sharesave Scheme, at an option
price of £6.63 per Share.
Participant British American Tobacco Shares Total Beneficial and Family
purchased Interests following this
Notification
R Kindts 1,429 66,947 (including 23,482 Deferred
Shares)
J Rembiszewski 1,429 74,735 (including 45,315 Deferred
Shares)
Name of duly authorised officer of issuer responsible for making notification:
A E Griffiths
Assistant Company Secretary
0207 845 1920
2 January 2008
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.